Imperial falls in steady FTSE 100, Burberry up 9% 08:36 , Graeme Evans The FTSE 100-listed shares ...

GSK Plc agreed to buy an experimental medicine to treat liver disease for as much as $2 billion as the UK drugmaker seeks to shore up its pipeline of new medicines.

From Burberry’s planned job cuts and Aviva’s £3.7bn takeover probe to China’s criticism of the UK-US trade pact, here are ...